05:31 AM EDT, 09/05/2025 (MT Newswires) -- Sophia Genetics ( SOPH ) said Friday it is collaborating with Jessa Ziekenhuis to expand genomic testing and oncology research in Belgium.

Under the deal, Jessa will adopt Sophia Genetics' ( SOPH ) DDM platform across its pathology operations to unify sequencing workflows, the company said.

Sophia Genetics ( SOPH ) said the collaboration will lower overall costs by up to 25% and support testing in solid tumors, hematologic malignancies and liquid biopsy analysis.

Financial terms of the deal were not disclosed.